Health-related quality of life in adults treated for paediatric acute lymphoblastic leukaemia: a cross-sectional and longitudinal cohort studyKatarina Aili, Susann Arvidsson, Maria Olsson, Marianne Jarfelt, Jens Nygren
7 January 2022
Cross-sectional study on knowledge, attitude and practice towards thalassaemia among Indonesian youthPustika Amalia Wahidiyat, Edward Christopher Yo, Muhammad Maulana Wildani, Visabella Rizky Triatmono, Mikhael Yosia
3 December 2021
Protocol for a multicentre, parallel-group, open-label randomised controlled trial comparing ferric carboxymaltose with the standard of care in anaemic Malawian pregnant women: the REVAMP trialMartin N Mwangi, Glory Mzembe, Ernest Moya, Sabine Braat, Rebecca Harding, Bjarne Robberstad, Julie Simpson, William Stones, Stephen Rogerson, Kabeya Biselele, Jobiba Chinkhumba, Leila Larson, Ricardo Ataíde, Kamija S Phiri, Sant-Rayn Pasricha
23 November 2021
Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort studyKaren Schow Jensen, Birgitte Klug Albertsen, Henrik Schrøder, Alina Zalounina Falborg, Kjeld Schmiegelow, Steen Rosthøj, Michael Thude Callesen, Peter Vedsted
22 November 2021
Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USAMatthew P Smeltzer, Kristen E Howell, Marsha Treadwell, Liliana Preiss, Allison A King, Jeffrey A Glassberg, Paula Tanabe, Sherif M Badawy, Lisa DiMartino, Robert Gibson, Julie Kanter, Lisa M Klesges, Jane S Hankins,
17 November 2021
Design of the HEM-POWR study: a prospective, observational study of real-world treatment with damoctocog alfa pegol in patients with haemophilia AMartin Sanabria, María Teresa Álvarez Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Johannes Oldenburg, Sabine Friedl, M T Reding
2 September 2021
Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocolKristin A Shimano, Rachael F Grace, Jenny M Despotovic, Ellis J Neufeld, Robert J Klaassen, Carolyn M Bennett, Clement Ma, Wendy B London, Cindy Neunert
27 August 2021
Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort studyKaren Schow Jensen, Birgitte Klug Albertsen, Henrik Schrøder, Alina Zalounina Falborg, Kjeld Schmiegelow, Steen Rosthøj, Michael Thude Callesen, Peter Vedsted
19 August 2021
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic reviewAbdullah Pandor, Michael Tonkins, Steve Goodacre, Katie Sworn, Mark Clowes, Xavier L Griffin, Mark Holland, Beverley J Hunt, Kerstin de Wit, Daniel Horner
29 July 2021
Sickle Cell Disease Genomics of Africa (SickleGenAfrica) Network: ethical framework and initial qualitative findings from community engagement in Ghana, Nigeria and TanzaniaKofi A Anie, Edeghonghon Olayemi, Vivian Paintsil, Ellis Owusu-Dabo, Titilope Adenike Adeyemo, Mahmoud U Sani, Najibah Aliyu Galadanci, Obiageli Nnodu, Furahini Tluway, David Nana Adjei, Peter Mensah, Joseph Sarfo-Antwi, Henry Nwokobia, Awwal Gambo, Adebola BenjaminSee the full list of authors
23 July 2021